Founded in 2016, the new Fischer Imaging is focused on improving outcomes for cancer patients with advanced imaging. Our proprietary technology doubles the resolution and contrast of today’s mammography using less than half the x-ray dose and removes the need for painful breast compression.
Our company succeeds Fischer Imaging Corp., with roots going back to 1910 when H.G. Fischer, the oldest manufacturer of X-ray imaging devices in the United States, began its operation in Chicago, IL. Since then, the reputation and name of the company have evolved and gained worldwide recognition in leveraging technology that has brought to market such innovations as the SenoScan Full Field Digital Mammography (FFDM) system and the MammoTest stereotactic breast biopsy system.
If you have any questions related to any of our medical devices then please send us an email!
MammoCATTM is based on our proprietary slot scanning technology. This produces images of significantly higher contrast and resolution (up to 25 microns) and almost eliminates scattered radiation without using a scatter removal grid. Today’s Full Field Digital Mammography (FFDM) mammography systems use grids to remove scatter and therefore require higher X-ray doses to get acceptable images. MammoCATTM DM, our first product, will provide superior FFDM images and can be upgraded in the field to our second product, MammoCATTM DBT, that will rival Digital Breast Tomosynthesis systems currently on the market. Our proprietary technology gives our DBT product the same advantages that it provides to MammoCATTM DM.
MammoCATTM CT will use the same imaging gantry as our DM and DBT products and allow stereotactic biopsy. All of these features, combined with the low dose, high resolution imaging will make it suitable for screening, diagnosis, staging and biopsy on the same system. This multi-purpose use will improve equipment utilization, hospital workflow and reduce demands on space.
The MammoCATTM technology platform affords superior image quality, low dose and patient comfort all in one system. Cost-effectiveness also distinguishes the MammoCATTM from all current mammography systems now in clinical use.
All MammoCATTM products are currently under development and are not available for sale at this time.
For over 100 years the Fischer name has been synonymous with quality diagnostic imaging and innovation. The new MammoCATTM product family continues the legacy.
We are available by e-mail. You can also use our quick
contact form to ask a question about our services that we regularly provide.